Navigation Links
NicOx Reports Results for the First Three Quarters of 2008
Date:10/22/2008

zer's decision not to launch a

phase 3 program.

Eric Castaldi, Chief Financial Officer at NicOx, said: "During the third quarter of 2008 we have achieved considerable success in the development of naproxcinod, while keeping the necessary control on expenses. We are very encouraged by the positive top-line results from the 302 phase 3 study, which comfortably met its efficacy endpoints and supported naproxcinod's non-detrimental effect on blood pressure, as well as by the good long term safety data observed in the 301 extension study.

We have also significantly advanced our pre-launch activities for naproxcinod, through the signature of an agreement for the manufacture of naproxcinod capsules for future commercialization, and are confident that the New Drug Application will be filed in mid 2009 as planned. We remain focused on the finalization of the clinical program for naproxcinod and look forward to the results of the 303 phase 3 study and the 111 and 112 Ambulatory Blood Pressure Monitoring studies in the coming months. As anticipated, our cash balance at the end of the third quarter is EUR124.8 million, which will enable us to fully finance the remaining clinical trials for naproxcinod and continue to advance the development of the other compounds in our portfolio."

Financial summary of the first nine months of 2008:

Revenues were EUR2.9 million for the nine months ended September 30, 2008, compared to EUR18.4 million during the same period in 2007. These revenues were due to the allocation of payments received from Pfizer Inc and Merck & Co., Inc. following the agreements signed with the two companies in the fields of ophthalmology and hypertension, respectively.

For the first nine months of 2008, operating expenses were EUR60.4 million, compared to EUR39.0 million for the corresponding period of 2007. As expected, the majority of these expenses were due to research and development costs related to naproxcinod, NicOx'
'/>"/>

SOURCE NicOx
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. NicOx Signs Agreement With Capsugel for the Commercial Manufacture of Naproxcinod Oral Capsules
2. NicOx Announces Departure of Damian Marron for CEO Position
3. NicOx Signs Agreement for the Commercial Manufacture of Naproxcinod Drug Substance
4. NicOx Initiates Two Large ABPM Studies for Naproxcinod in Hypertensive Patients with Osteoarthritis
5. NicOx to Present at Financial Conferences in New York on November 27, 28 and 29
6. NicOx Opens U.S. Headquarters in New Jersey
7. Wyeth Reports Earnings Results for the 2008 Third Quarter and First Nine Months
8. Sigma-Aldrich (Nasdaq: SIAL) Reports 18.5% Gain in Q3 2008 Diluted EPS and Reaffirms Full Year 2008 Diluted EPS Forecast. Q3 2008 Sales Increase 7.4%. Buyback Authorization Increased by 10 Million Shares.
9. Amylin Pharmaceuticals Reports Third Quarter Financial Results
10. Peregrine Pharmaceuticals Reports Progress in Its Phase II Trial of Bavituximab Plus Docetaxel in Patients With Advanced Breast Cancer
11. Glycotex Reports First Patient Enrollment in Phase IIb Study of Lead Product Candidate GLYC-101 for Wound Healing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... OncLive® is pleased to announce that ... Strategic Alliance Partnership program. , By participating ... will have the opportunity to work with the ... research initiatives, community-directed cancer prevention programs, and other ... OncLive to educate their peers by providing insights ...
(Date:7/23/2014)... Astra Nova Training , a ... pharma training services, and the Alliance for ... non-profit integrating the expertise and investments of research ... system for clinical trials, are pleased to announce ... of industry professionals through improved and easily available ...
(Date:7/22/2014)... D.C., June 22, 2014 Even within a phylum so ... is distinguished among other arthropods for its cruelty -- at ... Central America, the fly is a most predatory sort of ... cricket, deposits a smear of larvae, and leaves its wicked ... out. , None of this would be possible without ...
(Date:7/22/2014)... in mechanical engineering at the University of Texas at ... the North Texas section of the American Society of ... members in 158 countries who develop engineering standards and ... community, benefiting the world. , ASME recognized Baughn earlier ... honors banquet. Baughn retired as an engineering fellow in ...
Breaking Biology Technology:OncLive Expands Its Strategic Alliance Partnership Program With the Addition of UNC Lineberger Comprehensive Cancer Center 2OncLive Expands Its Strategic Alliance Partnership Program With the Addition of UNC Lineberger Comprehensive Cancer Center 3Astra Nova and ACRES Partner on Quality and Access of Training for Research Professionals 2Astra Nova and ACRES Partner on Quality and Access of Training for Research Professionals 3Fly-inspired sound detector 2Fly-inspired sound detector 3Fly-inspired sound detector 4UT Dallas professor receives Engineer of the Year award 2
... JUPITER, Fla., April 11, 2012 BioRestorative Therapies, Inc. ... a life sciences company focused on cellular therapies for ... on the previously announced license agreement with Regenerative Sciences, ... the treatment of bulging and herniated discs. This treatment ...
... 2012  Mars, Incorporated, as an official partner of ... across its Petcare, Chocolate, Wrigley, Food and Symbioscience ... leading food companies, it is seeking to improve ... leadership and collaboration. TEDMED ( www.tedmed.com ...
...  Spherix Incorporated (NASDAQ: SPEX ) – ... metabolic syndrome and atherosclerosis, and providers of technical ... and pharmaceutical companies – would like to remind ... a conference call to provide a business update ...
Cached Biology Technology:BioRestorative Therapies Announces Closing of License Agreement for Adult Stem Cell Disc/Spine Procedure 2BioRestorative Therapies Announces Closing of License Agreement for Adult Stem Cell Disc/Spine Procedure 3Mars, Incorporated Answers Question: 'How Does Feeding People and Pets Nurture Science and Discovery?' At TEDMED 2012 2Mars, Incorporated Answers Question: 'How Does Feeding People and Pets Nurture Science and Discovery?' At TEDMED 2012 3Mars, Incorporated Answers Question: 'How Does Feeding People and Pets Nurture Science and Discovery?' At TEDMED 2012 4Reminder: Spherix to Hold Business Update Conference Call April 11 at 1:00 p.m. Eastern Time 2Reminder: Spherix to Hold Business Update Conference Call April 11 at 1:00 p.m. Eastern Time 3
(Date:7/23/2014)... , July 23, 2014 ... threat detection, announced today it has been named in ... The Market Guide replaces Gartner,s well-known Magic Quadrant for ... categorized BioCatch as one of several vendors to deliver ... analysis will become a standard feature of at least ...
(Date:7/23/2014)... potential for clinical use of induced pluripotent stem ... previously been hindered by the risk of dysregulated ... ability to use etoposide treatment to halt teratoma ... disease, specifically acute myocardial infarction, is demonstrated in ... , a peer-reviewed journal from Mary Ann Liebert, ...
(Date:7/23/2014)... the International Journal of Fuzzy Systems ( ... Systems Association (TFSA). The cooperation will allow the journal ... fuzzy research., The International Journal of Fuzzy Systems ... with the theory, design and application of fuzzy systems, ... ranging from hardware to software. Launched in 1999, the ...
Breaking Biology News(10 mins):BioCatch Featured in Gartner's 2014 Online Fraud Detection Market Guide 2BioCatch Featured in Gartner's 2014 Online Fraud Detection Market Guide 3
... has identified a new genetic mutation responsible for osteogenesis imperfecta ... break, according to a study published today in the journal ... fractures in a lifetime or several hundred beginning before birth. ... from 20,000 to 50,000. While the study is an important ...
... combination of satellite data, computer models and weather balloon ... fires as much as doubled ground-level ozone thousands of ... July 2004. The study, which will appear online Sept. ... a rare glimpse at the precise air-quality effects from ...
... 1930s to estimate the abundance of fish has shown ... at reducing poaching of elephants, African buffaloes and black ... , "Wildlife within protected areas is under increasing threat ... argue that enforcement within protected areas is not sufficient ...
Cached Biology News:Researchers discover new gene responsible for brittle bone disease 2Researchers discover new gene responsible for brittle bone disease 3NASA study: Alaskan fires affected Houston air quality in 2004 2NASA study: Alaskan fires affected Houston air quality in 2004 3Serengeti patrols cut poaching of buffalo, elephants, rhinos 2
Lysozyme C (W-20)...
Abgene's ALTO-8 is the first automated decapper/capper for Abgene Twist-Lock tubes....
... refrigerated multifunction centrifuges are equally capable of high ... sound level with a large range of rotors ... exchange system without tools ensures that the required ... Instant rotor exchange (5 sec.) with ...
versican (H-56)...
Biology Products: